A
Aviral Kumar
Researcher at Indian Institutes of Technology
Publications - 33
Citations - 329
Aviral Kumar is an academic researcher from Indian Institutes of Technology. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 5, co-authored 15 publications receiving 78 citations. Previous affiliations of Aviral Kumar include Indian Institute of Technology Guwahati & Centre for Cellular and Molecular Biology.
Papers
More filters
Journal ArticleDOI
MicroRNAs as Modulators of Oral Tumorigenesis—A Focused Review
Kumar Rishabh,Soham Khadilkar,Aviral Kumar,Ishu Kalra,Alan Prem Kumar,Ajaikumar B. Kunnumakkara +5 more
TL;DR: In this paper, the role of microRNAs in regulating various hallmarks of oral tumorigenesis is discussed, including sustaining proliferative signaling, evading growth suppressors, resisting cell death activating invasion and metastasis, and inducing angiogenesis.
Journal ArticleDOI
Long noncoding RNAs in triple-negative breast cancer: A new frontier in the regulation of tumorigenesis.
Krishan Kumar Thakur,Aviral Kumar,Kishore Banik,Elika Verma,Elina Khatoon,Choudhary Harsha,Gautam Sethi,Subash C. Gupta,Ajaikumar B. Kunnumakkara +8 more
TL;DR: In this paper, a review highlights the association of several lncRNAs in TNBC progression and treatment, along with their possible functions and mechanisms, and extensive research is being carried out to reveal it.
Journal ArticleDOI
EMT in breast cancer metastasis: an interplay of microRNAs, signaling pathways and circulating tumor cells.
TL;DR: The significance of up and down regulated microRNAs in the pathogenesis and progression of breast cancer and how such micro RNAs could be treated as potential therapeutic targets to circumvent cancer are focused on.
Journal ArticleDOI
Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases
Uzini Devi Daimary,Dey Parama,Varsha Rana,Kishore Banik,Aviral Kumar,Choudhary Harsha,Ajaikumar B. Kunnumakkara +6 more
TL;DR: The current review focuses on highlighting the underlying molecular mechanism of action of cardamonin and delineating its potential in the prevention and treatment of different chronic diseases.
Journal ArticleDOI
Vimentin activation in early apoptotic cancer cells errands survival pathways during DNA damage inducer CPT treatment in colon carcinoma model.
Souneek Chakraborty,Souneek Chakraborty,Aviral Kumar,Mir Mohd Faheem,Archana Katoch,Archana Katoch,Anmol Kumar,Vijay Lakshmi Jamwal,Debasis Nayak,Debasis Nayak,Aparna Golani,Reyaz ur Rasool,Reyaz ur Rasool,Syed Mudabir Ahmad,Syed Mudabir Ahmad,Jedy Jose,Rakesh Kumar,Sumit G. Gandhi,Lekha Dinesh Kumar,Anindya Goswami,Anindya Goswami +20 more
TL;DR: The findings revealed a resistance strategy of cancer cells within a very initial period of drug treatment by activating EMT program, which hinders the cancer cells to achieve later phases of apoptosis thus increasing the chances of early migration.